143 related articles for article (PubMed ID: 38558564)
1. The role of inflammatory and remodelling biomarkers in patients with non-small cell lung cancer.
Omer HA; Janson C; Amin K
Cent Eur J Immunol; 2023; 48(4):330-337. PubMed ID: 38558564
[TBL] [Abstract][Full Text] [Related]
2. TGFβ1, SMAD2, CTNNβ1, and Wnt3a gene mutational status and serum concentrations in individuals with non-small cell lung cancer.
Omer HA; Amin K
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):81-91. PubMed ID: 38015536
[TBL] [Abstract][Full Text] [Related]
3. Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients.
Fu BH; Fu ZZ; Meng W; Gu T; Sun XD; Zhang Z
Tumour Biol; 2015 Aug; 36(8):6477-83. PubMed ID: 25820820
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between Expression of TGF-β1, Smad2, Smad4 and Prognosis
of Patients with Resected Non-small Cell Lung Cancer].
Xie M; He C; Wei S
Zhongguo Fei Ai Za Zhi; 2015 Sep; 18(9):543-8. PubMed ID: 26383977
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients.
Wang S; Han X; Hu X; Wang X; Zhao L; Tang L; Feng Y; Wu D; Sun Y; Shi Y
Clin Chim Acta; 2014 Mar; 430():63-70. PubMed ID: 24378285
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer.
Liu SG; Yuan SH; Wu HY; Liu J; Huang CS
Cell Biochem Biophys; 2015 May; 72(1):165-9. PubMed ID: 25548002
[TBL] [Abstract][Full Text] [Related]
7. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Wnt/beta-catenin signaling on the phenotype change of human dermal fibroblasts and its mechanism].
Liu JQ; Pan Q; Wang YC; Liu Y; Wang YJ; Bai L; Bai XZ; Hu DH
Zhonghua Shao Shang Za Zhi; 2012 Aug; 28(4):282-7. PubMed ID: 23248963
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-β1.
Huang J; Yu Q; Zhang J; Lu W; Liu Q; Chu Y; Zhou Y; Tu R; Zhou H; Wang Q
Curr Pharm Biotechnol; 2023; 24(8):1059-1069. PubMed ID: 35909269
[TBL] [Abstract][Full Text] [Related]
10. Catalpol inhibits TGF-β1-induced epithelial-mesenchymal transition in human non-small-cell lung cancer cells through the inactivation of Smad2/3 and NF-κB signaling pathways.
Wang Z; Lu Y; Sheng B; Ding Y; Cheng X
J Cell Biochem; 2019 Feb; 120(2):2251-2258. PubMed ID: 30203551
[TBL] [Abstract][Full Text] [Related]
11. MiR-21 regulates pulmonary hypertension in rats via TGF-β1/Smad2 signaling pathway.
Ding F; You T; Hou XD; Yi K; Liu XG; Zhang P; Wang XK
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3984-3992. PubMed ID: 31115027
[TBL] [Abstract][Full Text] [Related]
12. Association of CT perfusion imaging with plasma levels of TGF-β1 and VEGF in patients with NSCLC.
Li DW; Wu BZ; Shi YS; Li ZQ; Liu XD; Li XH
Asian Pac J Trop Med; 2016 Feb; 9(2):177-9. PubMed ID: 26919951
[TBL] [Abstract][Full Text] [Related]
13. lncRA ANCR Inhibits Non-Small Cell Lung Cancer Cell Migration and Invasion by Inactivating TGF-β Pathway.
Wang S; Lan F; Xia Y
Med Sci Monit; 2018 Aug; 24():6002-6009. PubMed ID: 30154397
[TBL] [Abstract][Full Text] [Related]
14. Association between Cardiovascular Response and Inflammatory Cytokines in Non-Small Cell Lung Cancer Patients.
Wang X; Cao M; Liu Z; Chen L; Zhou Y; Gao P; Zou Y
J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103052
[TBL] [Abstract][Full Text] [Related]
15. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum levels of VEGF and TGF-β1 with radiosensitivity of elderly patients with unresectable non-small cell lung cancer.
Fu ZZ; Gu T; Fu BH; Hua HX; Yang S; Zhang YQ; Gao LM; Li P
Tumour Biol; 2014 May; 35(5):4785-9. PubMed ID: 24557540
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis.
Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H
Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997
[TBL] [Abstract][Full Text] [Related]
19. DEK-targeting aptamer DTA-64 attenuates bronchial EMT-mediated airway remodelling by suppressing TGF-β1/Smad, MAPK and PI3K signalling pathway in asthma.
Song Y; Wang Z; Jiang J; Piao Y; Li L; Xu C; Piao H; Li L; Yan G
J Cell Mol Med; 2020 Dec; 24(23):13739-13750. PubMed ID: 33124760
[TBL] [Abstract][Full Text] [Related]
20. Effect of TGF-β1 on blood CD4
Hu Y; Qi W; Sun L; Zhou H; Zhou B; Yang Z
Exp Ther Med; 2018 Aug; 16(2):1403-1410. PubMed ID: 30112067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
